Skip to content
Teethgrinder – Lifestyle
Author:
PreludeDx
PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® – Early-Stage Invasive Breast Cancer Assay
April 29, 2026
PreludeDx Announces Publication in Breast Cancer Research Validating AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
March 12, 2026